It's a cracker of a result.
While growth in full-year Profit Before Tax was an impressive 16%, this masks the strong second-half growth of 21% (first half growth was 10%).
And it's not a case of the company cycling a weak base to achieve that 21% increase, because Pre-Tax Profit for DY2017 was, itself, some 13% higher than its pcp.
So, she's compounding at quite a rapid clip.
I have to concede that I don't really know what it is that this company does so well - what it's "secret herbs 'n spices" are - that will allow it to continue to prosper in the years ahead.
Any opinions?
- Forums
- ASX - By Stock
- DDR
- Ann: 2018 Annual Report
DDR
dicker data limited
Add to My Watchlist
0.88%
!
$8.03

Ann: 2018 Annual Report, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.03 |
Change
0.070(0.88%) |
Mkt cap ! $1.450B |
Open | High | Low | Value | Volume |
$7.98 | $8.07 | $7.98 | $4.749M | 592.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1553 | $8.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.07 | 3312 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 6638 | 8.000 |
1 | 600 | 7.990 |
4 | 10890 | 7.980 |
6 | 2338 | 7.960 |
7 | 5200 | 7.950 |
Price($) | Vol. | No. |
---|---|---|
8.090 | 424 | 1 |
8.200 | 1250 | 1 |
8.250 | 1091 | 1 |
8.280 | 510 | 1 |
8.300 | 10040 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
DDR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online